Introduction
Clinical trials are important for identifying and evaluating the effects of new technologies, programs, and treatments on health outcomes, especially for growing populations [1] [2] [3] [4] . The recruitment to clinical trials of racial/ethnic minorities generally, and Asian Americans specifically, is low. In a meta-analysis of 30 years of minority participation in randomized controlled trials (RCTs) for cardiovascular disease, of the 45 trials identified, only 11 reported participants' race [5] . Of these 11 studies, 4 reported including Asian Americans with percentages ranging from 1.4% to 5%. Similarly, in a review of panic disorder community trials, 21 of the 47 reviewed studies reported minority inclusion [6] . Of these studies, eight studies included Asian Americans, which comprised only 1.1% of recruited participants (range = 0.4%-5.5%) for a total of 31 participants (range = [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . A systematic review of RCTs for obsessive-compulsive disorder identified 40 RCTs, of which 21 provided ethnic/racial participation data. Of the 21 studies, 12 reported Asian American rates of 0.6%-17.5% (numbers range from 1 to 11) [7] . In a systematic review of community-based participatory research (CBPR) studies, 17 of 19 reported minority participation. Only two of these studies included Asian participants (one with 100% and one with 1%) [8] . In 10 sites reporting population and recruitment rates for the prostate, lung, colorectal, and ovarian (PLCO) screening trials, overall, 3.6% of participants were Asian Americans, although they represented 5.4% of the population [9] . Of the 10 sites, 9 reported from 0.1% to 3.6% Asian Americans, and 1 reported 43% Asian/Pacific Islander participation when 72.9% of the local population was eligible. Such low rates of participation preclude reporting trial outcomes for subgroups [5, 7] .
Asian American communities have low knowledge of and negative attitudes toward clinical trials [10, 11] . In one study of Asian American cancer patients, 62% reported no knowledge of clinical trials [12] . In these studies, facilitators of interest in clinical trials included a recommendation by a trusted health-care provider, materials available in their own language, a supportive family, and good doctor-patient communication, sensitive to cultural beliefs.
In a survey study of cancer patients and healthcare providers, Asian Americans were less likely than other groups to have heard the term 'clinical trials', to know someone who had participated in a RCT, and to be willing to participate in a RCT [13] . These respondents were more likely to think of RCTs as experiments and were concerned about insurance coverage and costs of care. To better address health disparities, public health efforts need to foster a greater understanding of the factors that may motivate or impede Asian Americans' participation in clinical trials.
Asian American community's values and knowledge about clinical trials have not been fully explored [12] . The purpose of this study was to identify knowledge, barriers, facilitators, and cultural influences on participating in clinical trials among three Asian American ethnic groups. Identifying mechanisms and messages to facilitate information dissemination and promotion strategies to improve clinical trial participation was a goal.
Methods

Participants and instrumentation
Chinese, Korean, and Vietnamese communities were selected because they are primary target audiences for the Center for Asian Health. The Center for Asian Health has long-standing community partnerships with the Asian Health Coalition, a network of approximately 100 agencies serving the Asian American catchment area. Partner agencies who volunteered had capacity to recruit sufficient focus group numbers and identified at least two community members willing to help with recruitment and implementation.
Churches, community centers, and others publicized the focus groups by making announcements from community leaders, handing out flyers, and promoting 'word of mouth'. Participants were paid US$15.00 each plus refreshments and a raffle drawing. Each organization received US$200 for assistance recruiting and hosting focus groups. From November 2011 to February 2012, purposive sampling was used to recruit 103 adults for one of eight focus groups in the New York and Philadelphia metropolitan areas. Chinese participants (n = 55) were recruited from both cities. Korean (n = 18) and Vietnamese (n = 30) participants were recruited from Philadelphia.
All investigators, including the moderator, completed training in focus group methodology. To review studies on improving clinical trial participation, modify the protocol, and create the moderator guide, the research team and community collaborators met twice to identify issues related to clinical trials and to discuss cultural concerns unique and common to Chinese, Korean, and Vietnamese communities. The team slightly modified demographic measures previously used by the Center for Asian Health and translated in native languages (Chinese (Mandarin), Korean, and Vietnamese) and English versions to confirm the translation and back translation and to verify balance. The final moderator guide focused on cancer screening, clinical trials, and biospecimen banking ( Table 1 ). The moderator, note-takers, and research staff attended a second workshop to review implementation of the final protocol.
Implementation
The Chinese moderator and a translator (Vietnamese and Korean groups) conducted focus groups in community settings with community partners. Institutional Review Board review and approval were gained from Temple University as part of a larger study [14] [15] [16] [17] . Focus groups were conducted at local community-based organizations and churches. The Asian American interest in clinical trials 329 length of discussion varied from 90 to 150 min. The focus groups that were conducted with Chinese American participants used Mandarin for discussion. Korean and Vietnamese American focus groups used English as the primary language with interpreters. Notes were taken in both English and the native language, and the discussions were audio-recorded.
At the beginning of each focus group, the study was explained to participants, questions were answered, and consent forms were signed. Focus groups were moderated by one Asian American investigator. At the beginning of each focus group, participants were asked to complete a quantitative survey that included demographics and participants' assessments of their knowledge of clinical trials. Demographics included the year participants were born, their gender, whether or not they were born in the United States, their ethnic background (Chinese, Vietnamese, or Korean), their marital status, education (elementary school or less, some high school, high school graduate, some college, and college graduate and above), employment (employed, unemployed, retired, homemaker, or student), and how well participants' spoke English. The quantitative survey also asked about access to medical care, including questions for whether or not participants had medical insurance or a regular physician to visit. Participants were asked, 'Do you know what a clinical trial is?' Possible responses were 'no', 'know a little/heard about it', 'know some', and 'know well'.
Data analysis
The brief survey of quantitative items was examined using chi-square and Pearson's correlation. Some categories were combined to minimize cell sizes under five. Logistic regression was also used to identify significant results, taking into consideration the other variables in the model to counteract multiple comparisons. All variables identified as significantly related to the dependent variable ( Table 2) were included in multivariate analyses. However, because one variable, education, remained in the model, only the bivariate results are displayed.
Recorded tapes were transcribed verbatim and translated into English by a native speaker. Themes were identified independently by two coders, one a member of the research team and one a newly hired research assistant. Some themes emerged from the data like the theme 'making contributions to science'. Other themes were responses to moderator guide questions such as asking if there were cultural or religious beliefs that would encourage or discourage participation in clinical trials. Questions of translation were referred back to the native speaker and checked against the original tapes.
Once agreement on themes was reached, one member of the research team coded 100% of codable text, and the research assistant double coded almost half (49%) exceeding the minimum standard for intercoder reliability of 10% for double coded text [18, 19] . Codable text excludes expressions like laughter and inaudible phrases. Inter-coder reliability and gender differences in the number of participant comments were assessed. Excellent agreement (95%) was found. Areas of disagreement were reviewed, and consensus was arrived at through discussion between the two coders. Male participants made up 40% (range = 16%-73%) of comments in the groups, which closely matched their percentage representation in the focus groups that included males. Although the coders looked for differences in the presence of themes across all eight focus groups, no differences were found including those by race/ ethnicity.
Results
Survey results on knowledge of clinical trials
Participants were on average 64 years of age, primarily female, married, retired, born outside of the United States, and had a high school degree or above ( Table 2) . One group had no male participants. Most participants reported that they lived in the United States an average of 22 years and spoke English 'not well'. Most participants had health insurance (85%) and a regular doctor (89%). A large proportion of participants reported that they knew nothing (61%) or a little (25%) about clinical trials. Some significant differences (Table 3) were identified for ethnicity, with Vietnamese groups reporting Table 3 . Table 4 includes a summary of identified themes and example quotes. 'Giving Hope' was identified as a key factor that may motivate participation in clinical trials. Participants discussed clinical trials as providing an opportunity to gain access to new treatment options. Many thought that those in the last stages of a disease progression would be most interested in a clinical trial. But some participants thought that patients would want some information about already identified lack of side effects and health benefit, although they did understand that there were many unknowns including risks and benefits. Some participants were under the misunderstanding that the non-experimental arm of a clinical trial would only be a placebo. Participants seemed unaware of the benefits of standard care for those in treatment and that clinical trials extend to health promotion and early treatment. Disagreement existed about the influence of incentives as some thought offering incentives was critical and others thought that most people would forgo incentives. Many participants were interested in contributing to science and to giving future generations better treatment options, another kind of hope. Medical doctors and health-care providers were mentioned as key advisors for patients and family, with some saying doctors played the most important role in decision making. Some concerns were voiced about a lack of trust in health-care providers. Participants wanted full disclosure and more information about the consent process. They were afraid that health-care professionals might exert pressure to be in a trial, and they also noted that doctors were not always right. Participants were most comfortable with a doctor of the same nationality and/ or one who spoke their language. Religion was described as not having an influence on decision making for clinical trials, although participants later reflected that some beliefs may have both positive and negative effects. Cultural beliefs like Yin-Yang and balancing hot and cold also were not seen as influential over decisions. Participants had many questions about clinical trials and suggested ways to promote clinical trials in the community. See Table 4 for a list of these suggestions.
Identified focus group themes
Discussion
Most of the comments that patients had about reasons for or against participating in clinical trials would likely resound with most patients considering participating in a study. The cultural element was most apparent in participants' suggestions for how to provide education and recruit Chinese, Korean, and Vietnamese communities. The information that participants requested is mostly covered by standard consent processes. However, participants in this study also wanted information on who conducts the research, the past effectiveness of the drugs, and how the drug works. The suggestions for promoting clinical trials are a good list for cultural tailoring for many ethnic groups. The offer of hope that could be offered by clinical trials for those at the end stage of disease was a salient theme across focus groups. Luque et al. [20] describes patients' expectations of hope as exchanges where participation in RCTs is contingent upon the expectation of receiving a therapeutic benefit. Clinical trials researchers refrain from the idea of offering hope because consent processes require a conservative approach to stating benefits. However, patients in this study were more concerned that they be given an assurance that if health benefits are found, they will be offered those benefits. Cases like the Tuskegee clinical trials should remind researchers that such options are not guaranteed. Given the high cost of therapies that have become available in the lifetimes of current patients like medical interventions for HIV, researchers should take seriously patients' concerns about benefiting from research in which they contribute.
Doctors play a critical role both in introducing and discussing clinical trials with their patients and in making recommendations [21] . However, many physicians do not talk to participants about clinical trials, and they perceive many barriers to talking to patients, including lack of cultural knowledge and unease with discussing patient concerns [22] . Prior strategies to improve minority participation in clinical trials have had mixed success. Direct mailing, the use of communications media like radio, and incentives do not always improve recruitment [6, [23] [24] [25] [26] . Other studies have reported higher response rates for direct mail when combined with community contacts and workshops [27] . Advertising placed in Chinese specific media [28] , printed media like brochures, fact sheets, and other short publications and web-based interventions has been effective in some Asian populations [29, 30] .
Improved community outreach efforts include training community members to be presenters for educational presentations and workshops, increasing health screenings and adherence to health care [24, 27, 31, 32] . Community recruiters can explain clinical trials in the participant's 'native' language, establish trust in health providers, and create a relationship between recruiters and participants that enhances retention and enhances adherence to protocols [31, 33, 34] .
Partnering with culturally appropriate, community-based partners for health interventions has advantages [28, 33, 35] . Community leaders can identify low-cost but culturally meaningful incentives and identify holidays and other community events that could facilitate or restrict recruitment opportunities [24, 28] .
Limitations
This study was meant to provide a range of participant beliefs and expectations and had several limitations. This convenience sample had a large percentage of study participants who were well connected to medical services, which may overestimate the community's knowledge of and interest in clinical trials. This may be partly due to the older age range of the sample. Expanding the study to capture younger participants, those with fewer years living in the United States and those not connected to a health-care system, would enhance the generalizability of these results.
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Although a wide range of participant education levels was represented in the sample, only about 25% had less than a high-school degree, which is unusual for participants of this age group. Populations with less than a high-school degree may need educational materials in both English and their native language, materials that include graphics, and materials to match different literacy levels. A quantitative community survey is needed to confirm the present results and improve sample representativeness. Because this study represented a community perspective, participants did not mention a number of strategies identified in other studies to promote minority recruitment to clinical trials [6, 13, 23, 24, 32] .
Conclusion
Improving access to clinical trials and recruiting sufficient numbers of this diverse community is an important 5-year goal to achieve Healthy People 2020 objectives and diminish Asian American health disparities [36] . Public health agencies should work with researchers to strategically improve clinical trial referral networks in order to bolster the number and diversity of Asian American participants in clinical trials. Clinical trial sites located in areas with large numbers of Asian Americans should over-recruit to reach sample sizes that would allow for analysis by race. Increasing use of CBPR models in geographic areas with concentrations of Asian American populations, partnering with Asian American community-based organizations, and including Asian Americans in health planning and policy meetings are important strategies to improve clinical trial recruitment [37] .
Clinical trials researchers also can improve Asian American recruitment by providing cultural sensitivity training to clinical recruitment staff including physicians. Clinical trials research needs to take advantage of new communication technologies and access social networks to provide flexible health education in native languages of the target population. Health information for Asian Americans is critically needed, including better health education interventions, collection of epidemiological and lifestyle data, and outcome evaluation from clinical trials with experience recruiting Asian Americans [2] . Asian American community members have narrow views of clinical trials, with many thinking that trials only address end-stage disease, situations where there are no other treatment options and always include placebos. Concepts such as Yin-Yang and hot and cold balance may be more applicable to clinical trials dealing with lifestyle issues such as smoking, obesity, physical fitness, or diet interventions. Stigmas about clinical trials include feeling like 'guinea pigs', concerns over consent processes, and trust. These community issues can be addressed by proactive, positive messaging.
Innovations in health care depend on clinical trials to identify effectiveness and important side effects in minority populations [12] . Public health initiatives documented dramatic improvements in health screening rates and adherence to treatment regimens reducing health disparities, yet Asian American populations have not seen such success [38, 39] . This study suggests that strategic outreach to Asian American communities could make gains in improving knowledge about and interest in clinical trials. Low levels of clinical trial participation and knowledge gaps [10] [11] [12] make efforts to better recruit Asians critically important.
